statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer Lenses (EVO ICL) for myopia, astigmatism and presbyopia, today...

STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel

STAAR Surgical to Report First Quarter Results on May 7, 2024

In recent trading, shares of Staar Surgical Co. (STAA) have crossed above the average analyst 12-month target price of 45.38, changing hands for 45.51/share...

STAA Crosses Above Average Analyst Target

STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024

Check out Paul Tudor Jones Stock Picks '

 Download GuruFolio Report of Paul Tudor Jones (Updated on 04/03/2024), Check out Jim Simons Stock Picks '

 Download GuruFolio Report of Jim Simons (Updated...

Staar Surgical Co's Meteoric Rise: Unpacking the 34% Surge in Just 3 Months

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer Lenses (EVO ICL) for myopia, astigmatism and presbyopia, comes to the...

STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024

Check out Paul Tudor Jones Stock Picks &raquo;

 Download GuruFolio Report of Paul Tudor Jones (Updated on 03/26/2024), Check out Jim Simons Stock Picks &raquo;

 Download GuruFolio Report of Jim...

Staar Surgical Co's Meteoric Rise: Unpacking the 13% Surge in Just 3 Months

Investors considering a purchase of Staar Surgical Co. (STAA) shares, but cautious about paying the going market price of 38.34/share, might benefit from considering selling puts among the...

Commit To Purchase Staar Surgical At $27.50, Earn 11.9% Annualized Using Options

STAAR Surgical Celebrates Three Million Implantable Collamer Lenses

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer Lenses (ICL) for myopia, astigmatism and presbyopia, today announced...

STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Volume	414,218.00
52-Wk High	$68.27
52-Wk Low	$26.66

Period	Estimated	Reported	Surprise	Result
Q1'24	$0.05	--	--	N/A
Q4'23	$0.17	$0.13	-25.25%	MISSED
Q3'23	$0.16	$0.30	84.49%	BEAT
Q2'23	$0.27	$0.40	48.41%	BEAT
Q1'23	$0.07	$0.18	144.20%	BEAT

STAA Staar Surgical Co.

About

Feed

News

Sentiment

Earnings

Fundamentals